Ibogaine is the primary active ingredient from the Tabernanthe iboga plant from Africa. Ibogaine is isolated from the purified extract of the roots of the Tabernanthe iboga. Initially used as a used as a remedy for fatigue and depression, Ibogaine hydrochloride was first extracted by the French in the late 1800’s. Ibogaine was first used for the treatment of opiate addiction in 1962.
Ibogaine continues to be used as the primary chemical agent for the Ibogaine detox in the treatment of opiate dependence.
Ibogaine precipitates and accelerates the opiate withdrawal state while simultaneously inducing a hallucinogenic state that dissociates the treated individual from physical discomfort. Central nervous system toxicity can follow this procedure, which mitigates the otherwise obvious comfort benefits. Ibogaine is banned in a number of countries and is not legally approved for clinical use in the United States. The practice of Ibogaine detox for opiate dependence is regarded as questionable by many professionals, especially when so many other safe and effective options that are FDA approved are readily available.